Bispecific antibodies are fast becoming a hot topic for research and development. ACROBiosystems offer a variety of protein targets for bispecific antibody research.
High-quality Fc receptor proteins are crucial for determining the efficacy of antibodies. ACROBiosystems roster of Fc receptors provides the ultimate in terms of verification and purity.
Multiple myeloma is a common hematological malignancy that has its origins in plasma cells. Despite treatment becoming more sophisticated, there is still currently no cure. However, immunotherapy targeting CD38/CD3 is proving to be very promising.